These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction. Abraham WT; Zile MR; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC JACC Heart Fail; 2015 Jun; 3(6):487-496. PubMed ID: 25982108 [TBL] [Abstract][Full Text] [Related]
43. Comparison of Frequency of Frailty and Severely Impaired Physical Function in Patients ≥60 Years Hospitalized With Acute Decompensated Heart Failure Versus Chronic Stable Heart Failure With Reduced and Preserved Left Ventricular Ejection Fraction. Reeves GR; Whellan DJ; Patel MJ; O'Connor CM; Duncan P; Eggebeen JD; Morgan TM; Hewston LA; Pastva AM; Kitzman DW Am J Cardiol; 2016 Jun; 117(12):1953-8. PubMed ID: 27156830 [TBL] [Abstract][Full Text] [Related]
44. Ambulatory extra-aortic counterpulsation in patients with moderate to severe chronic heart failure. Abraham WT; Aggarwal S; Prabhu SD; Cecere R; Pamboukian SV; Bank AJ; Sun B; Pae WE; Hayward CS; McCarthy PM; Peters WS; Verta P; Slaughter MS; JACC Heart Fail; 2014 Oct; 2(5):526-33. PubMed ID: 25301151 [TBL] [Abstract][Full Text] [Related]
45. Quality of life in advanced heart failure: role of mitral regurgitation. Hauptman PJ; Rector TS; Wentworth D; Kubo S Am Heart J; 2006 Jan; 151(1):213-8. PubMed ID: 16368321 [TBL] [Abstract][Full Text] [Related]
46. Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study. Mishra RK; Yang W; Roy J; Anderson AH; Bansal N; Chen J; DeFilippi C; Delafontaine P; Feldman HI; Kallem R; Kusek JW; Lora CM; Rosas SE; Go AS; Shlipak MG; Circ Heart Fail; 2015 Jul; 8(4):702-8. PubMed ID: 25985796 [TBL] [Abstract][Full Text] [Related]
47. Functional Status, Pulmonary Artery Pressure, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction. Dalos D; Mascherbauer J; Zotter-Tufaro C; Duca F; Kammerlander AA; Aschauer S; Bonderman D J Am Coll Cardiol; 2016 Jul; 68(2):189-99. PubMed ID: 27386773 [TBL] [Abstract][Full Text] [Related]
48. Erectile dysfunction in heart failure: correlation with severity, exercise performance, comorbidities, and heart failure treatment. Apostolo A; Vignati C; Brusoni D; Cattadori G; Contini M; Veglia F; Magrì D; Palermo P; Tedesco C; Doria E; Fiorentini C; Montorsi P; Agostoni P J Sex Med; 2009 Oct; 6(10):2795-805. PubMed ID: 19674255 [TBL] [Abstract][Full Text] [Related]
49. Diagnosis, Clinical Course, and 1-Year Outcome in Patients Hospitalized for Heart Failure With Preserved Ejection Fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry). Kapłon-Cieślicka A; Tymińska A; Peller M; Balsam P; Ozierański K; Galas M; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G Am J Cardiol; 2016 Aug; 118(4):535-42. PubMed ID: 27374606 [TBL] [Abstract][Full Text] [Related]
50. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction. Kanagala P; Arnold JR; Cheng ASH; Singh A; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP Int J Cardiovasc Imaging; 2020 Jan; 36(1):101-110. PubMed ID: 31401742 [TBL] [Abstract][Full Text] [Related]
51. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy. Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593 [TBL] [Abstract][Full Text] [Related]
53. [Study of the factors contributing to poor quality of life in chronic heart failure with reduced ejection fraction]. Ihsen Z; Khadija M; Marwa C; Imtinen BM; Fethia BM; Sofien K; Sondos K Ann Cardiol Angeiol (Paris); 2021 Oct; 70(4):231-236. PubMed ID: 34517976 [TBL] [Abstract][Full Text] [Related]
54. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Ammar KA; Jacobsen SJ; Mahoney DW; Kors JA; Redfield MM; Burnett JC; Rodeheffer RJ Circulation; 2007 Mar; 115(12):1563-70. PubMed ID: 17353436 [TBL] [Abstract][Full Text] [Related]
55. Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity). Wong CM; Hawkins NM; Jhund PS; MacDonald MR; Solomon SD; Granger CB; Yusuf S; Pfeffer MA; Swedberg K; Petrie MC; McMurray JJ J Am Coll Cardiol; 2013 Nov; 62(20):1845-54. PubMed ID: 23850914 [TBL] [Abstract][Full Text] [Related]
56. Clinical Implications of the New York Heart Association Classification. Caraballo C; Desai NR; Mulder H; Alhanti B; Wilson FP; Fiuzat M; Felker GM; Piña IL; O'Connor CM; Lindenfeld J; Januzzi JL; Cohen LS; Ahmad T J Am Heart Assoc; 2019 Dec; 8(23):e014240. PubMed ID: 31771438 [TBL] [Abstract][Full Text] [Related]
57. Exercise-induced B-lines identify worse functional and prognostic stage in heart failure patients with depressed left ventricular ejection fraction. Scali MC; Cortigiani L; Simionuc A; Gregori D; Marzilli M; Picano E Eur J Heart Fail; 2017 Nov; 19(11):1468-1478. PubMed ID: 28198075 [TBL] [Abstract][Full Text] [Related]
58. Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial. Huijts M; van Oostenbrugge RJ; Duits A; Burkard T; Muzzarelli S; Maeder MT; Schindler R; Pfisterer ME; Brunner-La Rocca HP; Eur J Heart Fail; 2013 Jun; 15(6):699-707. PubMed ID: 23384944 [TBL] [Abstract][Full Text] [Related]
59. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768 [TBL] [Abstract][Full Text] [Related]
60. A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: A preliminary report. Kloppe A; Mijic D; Schiedat F; Bogossian H; Mügge A; Rousso B; Lemke B Cardiol J; 2016; 23(1):114-9. PubMed ID: 26503077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]